Article
Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma.
International journal of molecular sciences - 4 May 2026
Fedorinov Denis, Lyadov Vladimir, Lyadova Marina, Abdullaev Sherzod, Kachanova Anastasia, Filatova Anna, Ivashchenko Dmitriy, Sychev Dmitry
Abstract excerpt
Despite the adoption of neoadjuvant FLOT chemotherapy as standard treatment for locally advanced gastric and gastroesophageal junction cancer, many patients fail to achieve meaningful pathological response, limiting efficacy. The aim of this study was to evaluate the impact of pharmacogenetic markers on pathological response in Russian patients receiving neoadjuvant FLOT. Thirty patients with locally advanced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
